Axelyf
@axelyf.com
Building Next-Generation RNA-LNP Therapeutics: experienced drug developers with distinctive technologies - for partners, programs and patients
Axelyf's Company Logos
Axelyf's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#D45D00
Tenn
212, 93, 0
26, 100, 42
0, 56, 100, 17
#EEEEEE
Gallery
238, 238, 238
0, 0, 93
0, 0, 0, 7
#23282F
Shark
35, 40, 47
215, 15, 16
26, 15, 0, 82
About Axelyf
Axelyf, founded in 2022 in Iceland, focuses on designing and developing medicines for metabolic diseases and inflammatory conditions. The brand aims to utilize the safety of natural products to enhance health and well-being. Their primary focus is on creating novel prodrugs of Astaxanthin, a natural compound known for its deep red color and health benefits.
Utilizing Astaxanthin sourced from algae culture, Axelyf has developed a proprietary prodrug with optimized oral bioavailability for targeted delivery to the liver to address inflammation. The team, spread across Iceland, the UK, and the USA, collaborates virtually on innovative programs. With experts like Dr.
Örn Almarsson and Dr. John Lucas on board, Axelyf is at the forefront of pharmaceutical innovation. Through cutting-edge lipid technologies, Axelyf is paving the way for future advancements in therapeutic treatments
Company type
Privately Held
Year founded
2022
Company size
2-10 employees
